Related Experiment Video
Updated: May 14, 2026

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
The Italian screening program for primary congenital hypothyroidism: actions to improve screening, diagnosis,
A Cassio1, C Corbetta, I Antonozzi
1Department of Pediatrics, University of Bologna, Bologna, Italy.
Insights
Italy
Area of Science:
- Pediatric Endocrinology
- Neonatal Screening
- Public Health Surveillance
Background:
- The Italian congenital hypothyroidism (CH) screening program integrates neonatal screening, diagnosis, treatment, follow-up, and surveillance.
- The program aims to detect both severe permanent CH and milder forms benefiting from early therapy.
Purpose of the Study:
- To optimize the Italian CH screening program by harmonizing strategies and improving diagnostic and therapeutic approaches.
- To enhance the national surveillance of CH based on established guidelines and expert experience.
Main Methods:
- Leveraging national guidelines, expert centers' experience, and data from the Italian National Registry of Infants with CH.
- Promoting collaborative actions among key Italian medical societies and the National Institute of Health.
Main Results:
- Identified the need for program optimization and harmonization across Italian Regions.
- Initiated actions to improve diagnosis, treatment, follow-up, and surveillance of CH.
Conclusions:
- Continuous improvement and harmonization are crucial for the Italian CH screening program.
- Collaborative efforts are essential to enhance the care of infants with congenital hypothyroidism nationwide.
Abstract:
The Italian screening program for primary congenital hypothyroidism (CH) is an integrated system including neonatal screening, diagnosis, treatment, follow-up, and nationwide surveillance of the disease. The aim of the Italian screening program for CH is to identify not only babies with severe permanent CH (core target), but also babies with mild persistent and transient forms of CH who could have a benefit from an early replacement therapy (secondary target). In the last years, despite the important results obtained in terms of standardization of screening and follow-up procedures, it has become clear the need of optimizing the program in order to harmonize the screening strategy and the screening procedures among Regions, and to improve the diagnostic and therapeutic approach in all affected infants. On the basis of available guidelines, the experience of the Italian screening and clinical reference centers, and the knowledge derived from the nation-wide surveillance activity performed by the Italian National Registry of Infants with CH, the Italian Society for Pediatric Endocrinology and Diabetology together with the Italian Society for the Study of Metabolic Diseases and Neonatal Screening and the Italian National Institute of Health promoted actions aimed at improving diagnosis, treatment, follow-up and surveillance of CH in our country. In this paper the most important actions to improve the Italian screening program for CH are described.
Related Concept Videos
Preventive Healthcare Services
Hyperthyroidism I: Introduction
Hypothyroidism II: Pathophysiology

